SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Experiment: Peroxisomal Dysfunction Validation in Parkinson's Disease

experiment 1,458 words KG: PEX5

section:experiments kind:experiment topic:parkinsons

Contents

Peroxisomal Dysfunction Validation in Parkinson's Disease

Knowledge Graph

Related Hypotheses (3)

Smartphone-Detected Motor Variability Correction
Score: 0.56 Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45 Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44

Related Analyses (16)

TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived

Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · completed Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived

Related Experiments (30)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40 Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40 Levodopa-Induced Dyskinesias Mechanism — Experiment Design
validation · proposed · Score: 0.40

Cytochrome Therapeutics
clinical · proposed · Score: 0.40 Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40 Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40 Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40 Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.40 Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.40 Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.40 Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40 AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
validation · proposed · Score: 0.40 AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.40 AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.40 Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.40 Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40 Computational Modeling of Alpha-Synuclein Propagation in PD
validation · proposed · Score: 0.40 Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation
validation · proposed · Score: 0.40 Alpha-Synuclein Seed Amplification Assay Validation
clinical · proposed · Score: 0.40 Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation
exploratory · proposed · Score: 0.40 Antiviral Therapy Trial for Parkinson's Disease
clinical · proposed · Score: 0.40 Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson'
clinical · proposed · Score: 0.40 Axonal Transport Dysfunction Validation in Parkinson's Disea
clinical · proposed · Score: 0.40 cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Chaperone-Mediated Autophagy Dysfunction in PD - Experiment
clinical · proposed · Score: 0.40

Knowledge Graph (11 edges)

PEX5 activates PEX3

PEX5 activates GSK3

PEX5 activates Cancer

PEX5 participates_in autophagy pathway

PEX5 regulates multiple sclerosis

PEX5 expressed_in microglia

PEX5 expressed_in oligodendrocytes

PEX5 associated_with multiple sclerosis

PPAR activates PEX5

ATM interacts_with PEX5

SciDEX — scidex.ai — Dashboard | Atlas